Dashboard PDUFA PDUFA History Dilution Watch Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...

Free to browse, no account needed Track TECH with free AI briefings, catalyst countdowns, and dilution alerts.

TECH · Bio-Techne Corp

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

$264.7M Cash, Jun 2026

+1% Share Count, 1 Year

Follow TECH by email Get an email when TECH pushes back a promised milestone, files for a stock offering or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about TECH, unsubscribe in one click. Privacy

📣 What TECH Says Is Next

late 2026 · “The proposed transaction has been approved by Bio-Techne’s Board of Directors and the relevant corporate bodies of Merck KGaA, Darmstadt, Germany, and is expected to close by late 2026 or early 2027, subject to satisfaction of customary closing conditions, including receipt of required regulatory approvals and approval by Bio-Techne shareholders.”
Company press release, Jun 25, 2026 · SEC filing

Quoted word for word from the company's press releases filed with the SEC. Timing is the company's own guidance, not a BioRadar estimate.

💰 Cash Runway & Dilution Risk

TECH reported $264.7M in cash and short-term investments (as of Jun 30, 2026) and its operations are currently cash-flow neutral or positive.

Dilution pressure: 0 · Low

No operating cash burn in latest filings

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when TECH files for a raise →

Get the full TECH picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for TECH and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z